title: [Candidemia and invasive candidiasis in the adult: clinical forms and treatment].
abstract: Invasive candidiasis is progressively increasing in frequency as a complication of the hospitalised adult patient. The availability of new antifungal drugs with lower toxicity and high efficacy has increased the complexity of managing of these infections. In parallel, the costs of the treatment of invasive fungal infections have considerably increased. Finding of a balance between the best benefit for the patient with the less costs is, nowadays, one of the main objectives of the current recommendations for the management of invasive candidiasis. In this review, the recommendations for the management of candidemia and other forms of invasive candidiasis (esophagitis, peritonitis, ocular, cardiovascular and osteoarticular candidiasis, central nervous system and urinary tract candidiasis, and chronic disseminated candidiasis) are analysed.
authors.affiliation: Servicio de Enfermedades Infecciosas, Hospital Clínic de Barcelona - IDIBAPS, Barcelona, España. carloscerveraalvarez@Gmail.Com
authors.forename: Carlos
authors.initials: C
authors.lastname: Cervera
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D058387:Candidemia / Q000188:drug therapy / Q000191:economics; D058365:Candidiasis, Invasive / Q000188:drug therapy* / Q000191:economics; D000075202:Contraindications; D003362:Cost-Benefit Analysis; D019468:Disease Management; D005260:Female; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000150:complications; D009928:Organ Specificity; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000188:drug therapy / Q000382:microbiology; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000382:microbiology; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000382:microbiology; D013045:Species Specificity
chemical_list: D000935:Antifungal Agents